Inventor · disambiguated record
Mark Powell
Also filed as: POWELL MARK · POWELL MARK T
7 granted patents·7 pending applications·14 citations·filing 2002–2012
76Inventor score
Files withJACKSON PAUL F5RIGEL PHARMACEUTICALS INC4JANSSEN PHARMACEUTICA NV2BATTISTA KATHLEEN A1CHAKRAVARTY DEVRAJ1
Top patents by PatentIndex Score
14 records- 0183US7579356B2Thia-tetraazaacenaphthylene kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 25, 2009·9 cites·27 claims
- 0273US6890725B2Modulators of B-lymphocyte activation, myosin-1F compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2002·Granted May 10, 2005·2 cites·25 claims
- 0371US6929923B2Modulators of leukocyte activation, BIC compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Aug 16, 2005·2 cites·20 claims
- 0461US8748624B2Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonistsCHAKRAVARTY DEVRAJ·Filed 2012·Granted Jun 10, 2014·1 cites·22 claims
- 0560US7427625B2Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 23, 2008·0 cites·19 claims
- 0660US2008300264A1Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitorsCONNOLLY PETER J·Filed 2008·Application pending·0 cites
- 0749US7371537B2Modulators of B-lymphocyte activation, myosin-1F compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2005·Granted May 13, 2008·0 cites·8 claims
- 0843US2008108611A1Substituted thienopyrimidine kinase inhibitorsBATTISTA KATHLEEN A·Filed 2007·Application pending·0 cites
- 0940US7067266B2Modulators of leukocyte activation, Hck compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jun 27, 2006·0 cites·26 claims
- 1038US2011105541A1ALKYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTSJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 1137US2011105540A12-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 1236US2011105494A1Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonistsJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 1336US2011105493A1HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTSJACKSON PAUL F·Filed 2010·Application pending·0 cites
- 1436US2011105492A1ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTSJACKSON PAUL F·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Powell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →